Ai Mediq took part at the conference “Bringing innovation to the health tech market” hosted by Luxinnovation on 19 September 2019. The key question being discussed at the conference were Regulatory aspects.
ESC Congress 2019 combined with WCC2019 in Paris
Ai Mediq took part in the Congress of European Society of Cardiology 2019 in Paris, France. This year Ai Mediq has had detailed feedback from key opinion leaders and are looking into possible options to introduce ReOxy, our core product, to rehabilitation of chronic heart failure patients
Medica 2019
Ai Mediq is looking forward to seeing all our existing partners and new potential collaborators at joint booth of Ministry of Economy of Grand Duchy of Luxembourg. The booth number remained the same A74 in Hall 3, so you should have no problems locating us. See you in Dusseldorf. P.S. Distributors wanted.
Cardiac Rehabilitation of Elderly – New Trial in Italy
Last Friday (26th of July 2019) one of the most recent clinical trials involving ReOxy has been registered with CliniclTrials.gov database with NCT04034082 identifier.
New clinical trial in CHF patients
Ai Mediq is pleased to announce approval of new clinical trial named “Evaluation of clinical efficacy of interval hypoxic-hyperoxic trainings in treatment of patients with reduced ejection fraction of left ventricle (2-3 NYHA)
ESC Congress 2019 combined with WCC2019 in Paris
Ai Mediq is pleased to announce participation in the annual meeting of European Society of Cardiology (ESC Congress) 2019 which will take place this time in Paris, France. For the first time …
Ai Mediq at Arab Health 2019: First national pavilion of Luxembourg
From January 28 till February 1, 2019, the Grand Duchy of Luxembourg (cooperation between the Ministry of the Economy, the Luxembourg Chamber and Commerce and the Luxembourg Trade and Investment Office in Abu Dhabi) had a national pavilion at Arab Health for the very first time. It was our pleasure meeting our customers and guest during Arab Health 2019 on First national pavilion of Luxembourg.…
Arab Health 2019
Ai Mediq announces it’s participation in largest professional event in MENA region – Arab Health 2018. The event will…
Hypoxic training: Clinical benefits on cardiometabolic risk factors
OBJECTIVES: The main aim of this review was to evaluate the effectiveness of hypoxic training on the modulation of cardiometabolic risk factors. DESIGN: Literature review. METHODS: An electronic search encompassing five databases (PUBMED, EMBASE, MEDLINE, CINAHL, and SPORTDiscus) was conducted. A total of 2138 articles were retrieved. After excluding non-relevant articles, duplications and outcomes not related to cardiometabolic risk factors, 25 articles were chosen for…
23-rd international exhibition “Zdravookhranenie 2013”: “Healthcare, Medical Engineering and Pharmaceutics”.
Ai Mediq S.A. participated in 23-rd International Exhibition “Zdravookhranenie 2013”, hold with support of the Ministry of Health and Social Development of the Russian Federation, the Ministry of Industry and Trade of the Russian Federation, Russian academy of medical sciences, the Civic Chamber of the Russian Federation. Ai Mediq S.A presented new model ReOxy-Lux during «The Russian Health Care Week 2013». It is a largest…